eToro Secures $250 Million Revolving Credit Facility

eToro Secures $250 Million Revolving Credit Facility GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, today announced the closing of a new three year $250 million senior unsecured revolving credit facility (“the Facility”). The Facility provides eToro […]

SILICOM’S SECOND QUARTER 2025 RESULTS RELEASE SCHEDULED FOR JULY 31, 2025

Conference Call Scheduled for Thursday, July 31, 2025 at 9:00am ET – Silicom Ltd. (NASDAQ: SILC), an industry-leading provider of high-performance server/appliances networking solutions,announced today that it will be releasing its second quarter 2025 results on Thursday, July 31, 2025. https://mma.prnewswire.com/media/733229/3093540/Silicom_Ltd_Logo.jpg The Company will be hosting a conference call on that same day at 9:00am

Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV’s Scientific Advisory Board

Veteran Global Clinical Leader, Honored for Helping Develop One of the First COVID Vaccines, to Support Rollout of PhaseV's New AI Platform for Clinical Development PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr. Ivarsson most

AsiaFIN’s e-Invoicing Solution Surpasses 100 Customers

INReport e-Invoice Empowers Malaysian Companies to Seamlessly Comply with New Nationwide Tax Mandate KUALA LUMPUR, MY / ACCESS Newswire / July 1, 2025 / AsiaFIN Holdings Corp. (OTCQB:ASFH), a leading fintech financial ecosystem enabler, today announced that its centralized regulatory technology (RegTech) solution, INReport e-Invoice, has surpassed 100 customers across Asia. INReport e-Invoice is a

PhaseV Announces New ClinOps AI Platform: Transforming Clinical Trial Operations with Precision-Guided Site Selection

Powered by Causal AI and Real-Time Patient-Level Data and Analytics, the ClinOps Platform Enables Faster and Smarter Decision Making Across Trial Lifecycles PhaseV, a leader in AI/ML-driven clinical development, today announced the launch of the ClinOps platform, a next-generation solution designed to modernize clinical trial operations through precision-guided site selection and dynamic performance monitoring. Built

AudioEye Expands European Union Presence with European Accessibility Act

Organizations face new digital accessibility requirements and rising penalties for non-compliance AudioEye, Inc. (Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company, has expanded its presence in the European Union to support growing demand as enforcement of the European Accessibility Act (“EAA”) begins. Now in effect, the EAA introduces wide-reaching requirements for businesses

Nuravax, Institute for Molecular Medicine to Present Phase 1 Results and Phase 2 Design of Alzheimer’s Vaccine AV-1959R at CTAD 2025

Two oral presentations to highlight the safety, immunogenicity, and future development of AV-1959R for primary and secondary prevention of Alzheimer's disease Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations-the Phase 1 clinical results and the Phase 2 secondary prevention study design for its licensed lead

Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace

Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,today announced it is listing 10 AI-integrateddata toolkits on Databricks Marketplace, an open marketplace for data, analytics and AI underpinned by the Databricks Data Intelligence Platform. https://mma.prnewswire.com/media/1323666/Health_Catalyst_Logo.jpg These data toolkits, which can be securely shared via

Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology(TM) platform and portfolio

Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology(TM) platform and portfolio GlobeNewswire July 01, 2025 Chief Executive Officer (CEO) Christian Kanstrup steps down Chief Scientific Officer Birgitte Rønø appointed interim CEO and search for new CEO has commenced Thomas Schmidt appointed permanent Chief Financial Officer COPENHAGEN, Denmark, July 1, 2025

KATE BURKE BEGINS ROLE AS CEO OF ALLSPRING GLOBAL INVESTMENTS

Allspring Global Investments™, a global asset management firm with $600 billion* in assets under advisement, announced that Kate Burke has assumed the role of Chief Executive Officer (CEO), effective today. https://mma.prnewswire.com/media/1839719/Allspring_Logo.jpg Kate joined Allspring in 2023 as President and also began service as a Director on the company's Board. She remains on the Board, and

Scroll to Top